Harmony Biosciences Holdings (HRMY)

Operating return on assets (Operating ROA)

		Dec 31, 2024	Sep 30, 2024	Jun 30, 2024	Mar 31, 2024	Dec 31, 2023	Sep 30, 2023	Jun 30, 2023	Mar 31, 2023	Dec 31, 2022	Sep 30, 2022	Jun 30, 2022	Mar 31, 2022	Dec 31, 2021	Sep 30, 2021	Jun 30, 2021
Operating income (ttm)	US$ in thousands	190,826	175,295	178,094	203,640	192,030	199,447	146,839	133,053	120,186	101,204	110,356	100,552	87,529	66,656	55,983
Total assets	US$ in thousands	999,200	928,135	858,383	846,985	811,448	777,766	760,183	715,092	673,870	643,464	505,034	464,005	433,443	391,092	359,695
Operating ROA		19.10%	18.89%	20.75%	24.04%	23.67%	25.64%	19.32%	18.61%	17.84%	15.73%	21.85%	21.67%	20.19%	17.04%	15.56%

December 31, 2024 calculation

Operating ROA = Operating income (ttm) ÷ Total assets
= $190,826K ÷ $999,200K
= 19.10%

Harmony Biosciences Holdings has shown a fluctuating trend in its operating return on assets (ROA) over the period from June 30, 2021, to December 31, 2024. The operating ROA started at 15.56% as of June 30, 2021, and increased gradually over the next few quarters, reaching its peak at 25.64% as of September 30, 2023.

After reaching this peak, there was a slight decline in the operating ROA figures but remained relatively strong, staying above 18% for the most part. As of December 31, 2024, the operating ROA stood at 19.10%, indicating that the company is effectively generating profits from its assets.

Overall, Harmony Biosciences Holdings has demonstrated a positive trend in its operating ROA, indicating its ability to generate operating profits relative to the size of its asset base. The fluctuations in the operating ROA numbers suggest some variability in the company's operational efficiency and profitability over the period analyzed.